Overview

Study of FX005 for the Treatment of Pain in Patients With Osteoarthritis of the Knee

Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, efficacy and pharmacokinetics of FX005 for the treatment of pain in patients with osteoarthritis of the knee.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Flexion Therapeutics, Inc.